Breaking Barriers in Disease Diagnosis: Expanding Access to Early Detection with Advanced Immunoassays

Join Dr. Laia Montoliu-Gaya, Assistant Professor from the University of Gothenburg, as she discusses recent advancements in Simoa® assays, designed to aid Alzheimer’s disease diagnosis and staging and expand access to broader populations.

Gain insight into the current state of the field, with a focus on Simoa assay development and application, as well as the technical innovations and strategic approaches scientists are using to drive progress.

Key learning objectives

  • Explore the recent developments in Simoa immunoassays
  • Learn about innovative applications and sample collection systems
  • Explore the application of both established and new Simoa biomarkers in Alzheimer’s disease
  • Learn more about expanding access to blood biomarkers for broader populations

Who should attend?

  • Neurology department heads and clinical directors
  • Research directors and principal investigators
  • Laboratory managers and diagnostics supervisors
  • Biotech and pharma R&D executives
  • Product development managers in medical diagnostics
  • Senior researchers in neurodegenerative disease
  • Clinical trial managers and coordinators
  • University research department: researchers, leads, chairs, and program directors

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Speakers

Dr. Laia Montoliu-Gaya
Assistant Professor, University of Gothenburg, Sweden

Dr. Laia Montoliu-Gaya, Assistant Professor at the University of Gothenburg, Sweden, is the inventor of a unique mass spectrometry method to detect tau species in blood for the diagnosis of Alzheimer’s disease. In addition, she is a co-inventor of a digital immunoassay for the quantification of p-tau205 in human biofluid and has also performed extensive work in diagnosing Alzheimer's disease in individuals with Down syndrome.

Moderator

Charlie Carter
Charlie Carter
Life Sciences Editor, SelectScience

Links

Tags